Type of Care:
Mental health treatment Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.):
Residential/24-hour residential
Facility Type:
Residential treatment center (RTC) for adults
Pharmacotherapies:
Chlorpromazine Droperidol Fluphenazine Haloperidol Loxapine Perphenazine Pimozide Prochlorperazine Thiothixene Thioridazine Trifluoperazine Aripiprazole Brexpiprazole Cariprazine Clozapine IIoperidone Lurasidone Olanzapine Olanzapine/Fluoxetine combination Paliperidone Quetiapine Risperidone Ziprasidone Nicotine replacement Non-nicotine smoking/tobacco cessation Antipsychotics used in treatment of SMI
Treatment Approaches:
Activity therapy Cognitive behavioral therapy Integrated Mental and Substance Use Disorder treatment Telemedicine/telehealth therapy
Facility Operation (e.g., Private, Public):
Private non-profit organization
Special Programs/Groups Offered:
Clients with co-occurring mental and substance use disorders Persons 18 and older with serious mental illness (SMI)
Assessment/Pre-treatment:
Screening for tobacco use
Recovery Support Services:
Housing services Mentoring/peer support
Education and Counseling Services:
Smoking/vaping/tobacco cessation counseling
Facility Smoking Policy :
Smoking not permitted
Age Groups Accepted:
Young Adults Adults Seniors
Facility Vaping Policy:
Vaping not permitted
Ancillary Services:
Diet and exercise counseling Illness management and recovery Psychosocial rehabilitation services Suicide prevention services Education services